Glucose metabolism causes activation of the yeast plasmamembrane H + -ATPase. The molecular mechanism of this regulation is not known, but it is probably mediated by phosphorylation of the enzyme. The involvement in this process of several kinases has been suggested but their actual role has not been proved. The physiological role of a calmodulin-dependent protein kinase in glucose-induced activation was investigated by studying the effect of specific calmodulin antagonists on the glucoseinduced ATPase kinetic changes in wild-type and two mutant strains affected in the glucose regulation of the enzyme. Preincubation of the cells with calmidazolium or compound 48\80 impeded the increase in ATPase activity by reducing the V max of the enzyme without modifying the apparent affinity for ATP in the three strains. In one mutant, pma1-T912A, the putative calmodulin-dependent protein kinase-phosphorylatable Thr-912 was eliminated, and in the other, pma1-P536L, H + -ATPase was
INTRODUCTION
The plasma-membrane H + -ATPase (Pma1) of yeast cells belongs to the family of P-type ATPases [1, 2] . It hydrolyses ATP and transports protons from the cytosol to the extracellular medium. The electrochemical gradient it creates is the driving force for nutrient uptake. The enzyme also plays an essential role in the maintenance of intracellular pH (for reviews see [3] [4] [5] [6] [7] ). The crucial physiological role of the ATPase requires its strict regulation. It is known that H + -ATPase activity is regulated in response to growth conditions [8] [9] [10] [11] , and glucose is the external signal that has been most extensively investigated. It has a dual role in regulating both the expression and catalytic activity of the plasma-membrane H + -ATPase. On the one hand, glucose metabolism increases ATPase gene (PMA1) transcription [12] and, on the other, it induces a modification of the enzyme's kinetic properties [8] , resulting in an overall stimulation of ATPase activity. The molecular mechanism of glucose-induced activation is not known, but it is based on the elimination of an inhibitory interaction of the C-terminus with the active site of the enzyme [13, 14] , probably mediated by Ser\Thr phosphorylation of the enzyme [15] . In fact, several C-terminal amino acids important in H + -ATPase regulation have been identified using site-directed mutagenesis [14, 16] . The residues that are essential for glucose activation define the potential phosphorylation sites for casein kinase II and calmodulin-dependent protein kinase II [17] which are necessary for the glucose-induced K m and V max changes respectively [14, 16] . The physiological role of casein kinase II in † To whom correspondence should be addressed.
constitutively activated, suggesting that the antagonistic effect was not mediated by a calmodulin-dependent protein kinase and not related to glucose regulation. This was corroborated when the in itro effect of the calmodulin antagonists on H + -ATPase activity was tested. Purified plasma membranes from glucosestarved or glucose-fermenting cells from both pma1-P890X, another constitutively activated ATPase mutant, and wild-type strains were preincubated with calmidazolium or melittin. In all cases, ATP hydrolysis was inhibited with an IC &! of $ 1 µM. This inhibition was reversed by calmodulin. Analysis of the calmodulin-binding protein pattern in the plasma-membrane fraction eliminates ATPase as the calmodulin target protein. We conclude that H + -ATPase inhibition by calmodulin antagonists is mediated by an as yet unidentified calmodulin-dependent membrane protein.
glucose-induced activation of the H + -ATPase is not known, although there is evidence that Ser-899, the phosphorylatable residue in the consensus site for this kinase, could be phosphorylated during glucose activation of the enzyme [16] . Involvement of a calmodulin-dependent protein kinase in glucose activation is less clear, since there is no evidence that Thr-912, the phosphorylatable residue in the ATPase consensus sequence for calmodulin-dependent protein kinase II, is phosphorylated [16] . Nevertheless, results obtained in i o using several kinase inhibitors [18] indicate that glucose-induced activation of the enzyme could be mediated by a calmodulin-dependent protein kinase. To unravel the role of calmodulin-dependent protein kinase in glucose activation of H + -ATPase, we studied the effect of calmodulin antagonists on the glucose-induced activation of glucose-regulation mutants. We describe potent inhibitory effects of these compounds that affect the V max of the enzyme, and we show, in i o and in itro, that these effects are not related to glucose regulation of the enzyme. The inhibition affects the basal activity of the enzyme and can be reversed by calmodulin, suggesting modulation of the H + -ATPase activity through a calmodulin-binding protein.
MATERIALS AND METHODS

Yeast strain and growth medium
The strain used was Saccharomyces cere isiae RS-72 transformed with pSB32, an autonomous and centromeric plasmid with the LEU2 gene for transformant selection [19] , containing a 5 kb HindIII fragment that includes either the wild-type or the selected mutant allele of the pma1 gene. RS-72 is a derivative of BWG1-7A (MATa, ade1-100, his4-519, leu2-3,112 and ura3-52) [20] in which the wild-type promoter of PMA1 has been replaced by the galactokinase gene (gal1) promoter [21] . Cells were grown in synthetic medium containing 2 % glucose or galactose, 0n7 % yeast nitrogen base without amino acids (Difco), 0n2 mM adenine and 0n4 mM histidine.
Chemicals
Calmidazolium, compound 48\80, melittin, calmodulin and suberic acid bis-(N-hydroxysuccinimide ester) (DSS) were obtained from Sigma Chemical Co. "#&I-calmodulin was from DuPont. All other chemicals used in this work were of analytical grade.
Expression of mutant ATPases
Mutants were grown to a final A ''! of 3 (about 10 mg fresh weight\ml) in galactose medium, in which both the wild-type (chromosomal) and mutant (plasmid) ATPases are expressed. To express the mutant enzyme only, the galactose-grown cells were diluted 100-fold in glucose medium and harvested after 24 h. In these conditions, cultures expressing active ATPase reach an A ''! of about 1n5 [21, 22] .
ATPase activation, homogenization and membrane preparation conditions
Yeast cells were harvested by centrifugation, washed twice with deionized water and resuspended at 70 mg fresh weight\ml in water to eliminate glucose activation [8] . For experiments with inhibitors, small aliquots of the compound dissolved in methanol were added to the cell suspension and the final methanol concentration was kept constant at 2 % (v\v). The results of control experiments with 0 or 2 % methanol were identical. After 30 min incubation at 30 mC, 5 ml samples were taken (glucosestarved cells), frozen in liquid nitrogen and stored at k70 mC until use. Then 2 % glucose was added to the rest of the suspension for glucose activation. Samples of volume 5 ml were taken after 8 min and frozen as above. Homogenization and membrane preparation were as previously described [8] .
ATPase activity
ATP hydrolysis was assayed with 2 mM ATP at 30 mC and pH 6n5, unless otherwise specified, in buffer containing 5 mM NaN $ to inhibit mitochondrial ATPase, 0n2 mM ammonium molybdate to inhibit acid phosphatase and 50 mM potassium nitrate to inhibit vacuolar ATPase. Residual activity represented specific ATP hydrolysis by the plasma-membrane H + -ATPase, as it was more than 90 % inhibited by 1 mM diethylstilboestrol [23] .
To measure the effect of inhibitors on ATPase activity, the assay buffer contained 0n1 mM CaCl # , and all enzyme assays were performed at a protein concentration of 20 µg\ml unless otherwise stated. Before initiating the reaction by ATP addition, the plasma membranes were preincubated with the drug for 5 min in the assay medium, followed by an additional 5 min in the absence or presence of calmodulin when indicated. Calmidazolium and compound 48\80 were dissolved in methanol. The final methanol concentration in the assay medium including the controls was always 4 % (v\v).
I-Calmodulin cross-link
"#&I-Calmodulin cross-linkage to plasma-membrane proteins was performed essentially as described [24] . Membrane fractions (80 µg of protein) were incubated at 37 mC for 30 min in 100 µl of 50 mM Hepes (sodium salt), pH 7n4, containing 1 mM PMSF, 200 µM CaCl # or 2 mM EGTA and 100 nCi of "#&I-calmodulin (90-110 µCi\µg). Samples were subsequently incubated at 0 mC for 20 min in the presence of a 3 mM concentration of the crosslinking agent DSS, and thereafter 250 mM glycine was added to terminate the reaction. Controls were performed with an excess (1n2 µM) of unlabelled calmodulin to displace the bound "#&I-calmodulin before addition to DSS. The samples were precipitated with 15 % (w\v) trichloroacetic acid, centrifuged in a microcentrifuge and the pellets processed for SDS\PAGE and autoradiography or Western blotting as described below.
Protein analysis
Protein concentration was measured by the Bradford method [25] , using the Bio-Rad protein assay reagent and bovine IgG as standard. SDS\PAGE was performed as described [26] in 6 % polyacrylamide gels. Samples were prepared as described [27] . The gels were stained with Coomassie Brilliant Blue R-250, and vacuum dried at 70 mC on Whatman 3MM filter paper. Autoradiographs were obtained using an intensifying screen by exposure of X-ray-sensitive Hyperfilm-MP (Amersham) at k20 mC. For Western-blot analysis, proteins were transferred to Immobilon P membranes (Millipore). Transfer buffer was 50 mM Tris\38 mM glycine\20 % methanol. Transfer was carried out for 1n5 h at a constant current of 2 mA\cm#. Immunodetection of ATPase was carried out using monoclonal antibody AT1-1-A4\1-A6 [28] diluted 1 : 6000. A second antibody coupled to alkaline phosphatase (Bio-Rad) was used as described [29] .
RESULTS
Effect of calmodulin antagonists on glucose-induced activation of H + -ATPase
One way to study the physiological role of the calmodulindependent protein kinase in plasma-membrane H + -ATPase activation by glucose is selective inhibition of its activity using specific calmodulin antagonists. Calmidazolium and compound 48\80 were selected on the basis of their wide use as calmodulinspecific inhibitors [30] [31] [32] . Table 1 shows that the in i o activation of the plasma-membrane H + -ATPase by glucose was progressively inhibited when cells were treated with increasing inhibitor concentrations before addition of glucose. Activation by glucose was virtually abolished at 400 µM calmidazolium or 400 µg\ml compound 48\80. These inhibitor concentrations were used in subsequent in i o experiments. The inhibitor concentration is higher than that used for specific enzyme inhibition in itro, as the cationic nature of these inhibitors limits their entry into the phospholipid phase of the membrane [33] . The results point to involvement of calmodulin-dependent protein kinase in glucose-induced activation of the H + -ATPase and are consistent with previous results [18] .
Effect of calmodulin antagonists on the glucose-induced changes in H + -ATPase kinetic parameters
Glucose treatment of wild-type cells induces important changes in the kinetic characteristics of plasma-membrane ATPase. Among them are a decrease in the K m for ATP and an increase in V max [8] . Some pma1 mutants that are affected in their glucose regulation have been described [13, 14, 16] in which these glucoseinduced kinetic parameters are altered in different ways. To specify further the extent to which the calmodulin antagonists affect glucose-induced activation of the ATPase, we measured their effect on the activity and kinetic properties of the enzyme in two such mutants. In one, pma1-T912A, elimination of the putative calmodulin-dependent protein kinase-phosphorylatable Thr-912, localized in the regulatory domain, results in an enzyme that is defective in the V max increase but which exhibits the typical glucose-triggered K m decrease. In the other mutant, pma1-P536L, the replacement of Pro-536 with leucine in the proposed ATPbinding domain probably eliminates the inhibitory interaction of the C-terminus with that domain resulting in a constitutively activated ATPase (K m and V max ), even in the absence of glucose metabolism. Preincubation with calmidazolium or compound 48\80 abolishes glucose activation in wild-type and mutant enzymes ( Table 2 ). The effect of calmidazolium on the kinetic parameter changes induced by glucose is shown in Table 3 . The K m decrease is produced in glucose-fermenting cells of the wildtype and pma1-T912A strains, whether they are treated with 
calmidazolium or not. This glucose-induced decrease in K m is not produced in the pma1-P536L mutant, as it was already low [16] , nor is this behaviour modified by calmidazolium. On the other hand, the glucose-induced V max increase is not produced in the wild-type strain, nor is the small increase in pma1-T912A observed. Even the glucose-independent constitutive effect of the P536L mutation is abolished in the presence of calmidazolium.
The results indicate that the calmodulin antagonists affect the V max of the enzyme, whereas the K m remains unaltered. This effect is unrelated to glucose activation since the calmodulin antagonists inhibit a mutant, pma1-P536L, the ATPase of which is completely independent of glucose metabolism. The results also suggest that the inhibitory effect of calmidazolium and compound 48\80 is not mediated by elimination of calmodulin-dependent phosphorylation of the ATPase, since these antagonists inhibit a mutant, pma1-T912A, in which the putative phosphorylatable residue has been eliminated.
Effect of calmodulin and calmidazolium on in vitro H + -ATPase activity
If a calmodulin-dependent protein kinase is not involved in the inhibition of the ATPase activity caused by calmodulin antagonists, it is feasible that another calmodulin-specific receptor system could be implicated. Several enzymes are known that possess an autoinhibitory domain that is removed on binding of calmodulin to the enzyme itself [34] , thereby activating the enzyme. The basal activity of these enzymes is stimulated in itro when the enzyme assay is performed in the presence of calmodulin. This calmodulin-stimulated activity can also be inhibited in itro by calmodulin antagonists. We have considered these possibilities. The ATPase activity in purified plasma membranes from glucose-starved or glucose-fermenting cells was not stimulated in the presence of calmodulin, not even in membranes obtained in the presence of EGTA to eliminate the Ca# + -dependent membrane-bound calmodulin pool (results not shown). This would suggest that either calmodulin is not a direct ATPase activator or cytosolic factors required for in i o activation are lost during isolation of plasma membranes. Lack of activation could also be explained by the existence of significant amounts of calmodulin tightly bound to the plasma-membrane fraction not solubilized during plasma-membrane isolation. Complete solubilization of endogenous calmodulin would require drastic treatments [35] which would abolish H + -ATPase activity.
When purified plasma membranes from glucose-starved or glucose-fermenting cells were preincubated with calmidazolium,
Figure 1 Concentration-dependence of in vitro H + -ATPase inhibition by calmidazolium
ATPase activity was measured in the presence of several concentrations of calmidazolium, as described in the Materials and methods section, using 10 ($), 20 (#) and 40 (>) µg/ml purified plasma membranes from glucose-fermenting cells. The ATPase activity of membranes not preincubated with the inhibitor, taken as 100 %, was 1n87p0n07 µmol/min per mg. Results are the means from three experiments. Inset, dependence of IC 50 on plasma-membrane concentration.
inhibition of the H + -ATPase activity was observed. In Figure 1 , the concentration-dependence of the inhibition caused by the calmodulin antagonist is shown at several plasma-membrane concentrations. The IC &! value for calmidazolium was different depending on the plasma-membrane concentration and varied from 1n1 to 3n0 µM at the protein concentrations assayed ( Figure  1, inset) .
Specificity of the inhibition of H + -ATPase activity by calmidazolium
Membrane-dependence suggested that much of the added inhibitor was binding to the membranes. Since calmodulin
Figure 2 Effect of calmodulin on the in vitro inhibition of ATPase activity by calmidazolium and melittin
ATPase activities were measured in purified plasma membranes from glucose-fermenting cells, as described in the Materials and methods section, at a protein concentration of 20 µg/ml. The membranes were preincubated with various concentrations of calmidazolium or melittin in the presence (#) or absence ($) of calmodulin (CaM). The ATPase activity of membranes not preincubated with calmodulin antagonists, taken as 100 %, was 2n32p0n1 µmol/min per mg. The results are means from three experiments.
antagonists can be considered to be cationic amphiphiles at physiological pH, interaction with the lipid portion of the membrane may take place. In fact, phospholipid-mediated effects caused by calmidazolium have been previously reported, based on 1 : 1 stoichiometric binding of inhibitor to phospholipid [36] . To dismiss this possibility, we estimated the stoichiometry of calmidazolium binding. Approximate values of the inhibition constant (K i ) and binding stoichiometry for calmidazolium can be obtained by a plot of IC &! against plasma-membrane concentration, where K i is the y intercept and 0n5 B the slope, where B is the binding stoichiometry in nmol\mg of protein [36] . A K i of 0n4 µM and B of 150 nmol\mg were calculated from the data of Figure 1 (inset) . The inhibitor does not appear to bind to membrane phospholipids with a 1 : 1 stoichiometry, since the calculated amount of calmidazolium bound is lower than the phospholipid content of the yeast plasma membrane [37] . Nevertheless, because of the dependence of the inhibition on plasmamembrane concentration, equal amounts of membranes were used in all experiments.
To assess the specificity of the inhibition of H + -ATPase activity, the effect of calmidazolium was compared with that of other calmodulin antagonists. Melittin is a high-affinity calmodulinbinding peptide [38] which inhibits calmodulin through a mechanism different from that of calmidazolium [39, 40] . In Figure 2 , the concentration-dependence of the inhibition caused by both calmodulin antagonists is shown. The IC &! values for calmidazolium and melittin, 1n4 µM and 1n1 µM respectively, were increased to 7n6 µM and 6n7 µM respectively in the presence of calmodulin. Calmidazolium-and melittin-caused inhibition of H + -ATPase activity occurs in purified plasma membranes from both glucose-starved and glucose-fermenting cells not only from wild-type, but also from pma1-P890X cells (results not shown). The P890X mutation generates a C-terminus deletion that produces an enzyme that is permanently in the activated state, independent of glucose fermentation [13, 16] .
Binding of calmodulin to plasma-membrane proteins
The above results do not reveal the calmodulin target for stimulation of H + -ATPase activity. It could be either a membrane component tightly coupled to the H + -ATPase or the enzyme itself. The calmodulin-binding domains of the target-binding proteins show extreme sequence variability, although they share an amphiphilic structure [41] . Yeast H + -ATPase has no obvious region with structural features of calmodulin-binding domains. Nevertheless, we tested the possibility that the inhibitory effect of the antagonists was mediated via elimination of calmodulin binding to the ATPase. Figure 3 shows the pattern of calmodulinbinding proteins of the plasma-membrane fraction from glucosefermenting cells obtained by "#&I-calmodulin cross-linking (similar results were obtained with membranes from glucose-starved cells ; not shown). Calmodulin actually bound to several plasmamembrane proteins in a Ca# + -dependent manner, and the binding of labelled calmodulin to these proteins was completely blocked by unlabelled calmodulin. However, no 116 kDa band corresponding to the calmodulin-ATPase complex was detected, indicating that the target for calmodulin binding is not the ATPase, but may rather be a membrane component.
DISCUSSION
The results presented here indicate that plasma-membrane H + -ATPase activity is greatly reduced by calmodulin antagonists. The inhibitors diminish the V max of H + -ATPase-catalysed ATP hydrolysis, although the apparent affinity for MgATP is not appreciably modified. Previous experiments using calmidazolium assigned a role in glucose-induced activation of H + -ATPase to one or more calmodulin-dependent kinases [18] . Our results show that the calmodulin antagonists affect the basal activity of the enzyme and that their inhibition is unrelated to activation by glucose, as shown by the response to the antagonists of several ATPase mutants affected in their glucose regulation. Thr-912 is the phosphorylatable residue located in the potential phosphorylation site for calmodulin-dependent protein kinase II, which is presumably involved in glucose regulation of the ATPase. A mutant lacking this residue should therefore not be affected by calmodulin antagonists. However, the V max of this mutant ATPase was reduced on calmidazolium treatment. Inhibition of mutant pma1-T912A together with the inhibition of a mutant whose ATPase is completely independent of glucose metabolism, pma1-P536L, demonstrate that a role in the activation of H + -ATPase by glucose cannot be assigned to a calmodulin-dependent protein kinase. Furthermore, inhibition of ATPase activity in purified plasma membranes excludes an effect of calmodulin antagonists via a calmodulin-dependent protein kinase and suggests that a membrane component is necessary for H + -ATPase activity as the calmodulin target. A role for a calmodulin-dependent protein kinase in glucose activation of the enzyme cannot be definitely ruled out, as it could be masked by the inhibition of the V max caused by these antagonists.
Many calmodulin inhibitors described are more or less nonspecific, in the sense that they are able to produce direct effects on calmodulin effector enzymes as well as phospholipid-mediated effects when used at high concentrations (50-75 µM) [35, 42] . The possibility that the action observed of calmodulin antagonists on H + -ATPase is non-specific seems unlikely, since this inhibition is produced in a concentration range that inhibits calmodulinmediated reactions in other systems (IC &! from 1 to 3 µM) [43, 44] . Moreover, that this effect could be mediated by antagonist interaction with calmodulin is indicated by the displacement of the IC &! values in the presence of calmodulin. Further evidence for the specificity of the calmodulin antagonists was obtained from the similar response produced when calmodulin antagonists with different modes of action were tested. Calmodulin antagonists exert their inhibitory action on calmodulin-dependent reactions by binding to the calmodulin molecule. Calmidazolium binds to calmodulin predominantly via hydrophobic interactions [39] , whereas not only hydrophobic but also electrostatic interaction contributes to melittin-calmodulin binding [40] .
Phospholipid-mediated effects by calmodulin antagonists have been previously reported, based on a 1 : 1 stoichiometric binding of inhibitor to phospholipid [36] . That this does not seem to be the case here is indicated by the fact that the phospholipid content of the yeast plasma membrane is higher than the apparent binding stoichiometry found for calmidazolium [37] . However, the dependence of the inhibition on membrane concentration indicates a large amount of bound calmidazolium. This could reflect the existence in the plasma membrane of several calmodulin-specific receptor systems (Figure 3 ) or even the interaction of part of the added inhibitor with the phospholipid portion of the plasma membrane. Therefore the results are compatible with the possibility that, of the large number of calmidazolium molecules that bind, only a small number is responsible for the specific inhibition of H + -ATPase activity.
Calmodulin regulates the activity of mammalian Ca# + -ATPase by interaction with the C-terminal domain [45] . The "#&I-calmodulin-binding protein pattern in the plasma-membrane fraction eliminates H + -ATPase as the calmodulin effector enzyme, and points to a membrane component being indispensable for its activity. Many membrane proteins exist as part of homooligomeric or hetero-oligomeric structures. In fact, there is a 115 kDa glycoprotein that remains tightly associated with H + -ATPase during purification of the enzyme [46] , although it is not essential for its activity [27] . It has recently been shown that two small proteolipids are at least partially associated with H + -ATPase in the plasma membrane [47] . A regulatory function for these proteolipids has been proposed, since a strain lacking both exhibited a lower V max for plasma-membrane H + -ATPase activity and a wild-type K m for MgATP. Both proteolipids are predicted to be amphipathic proteins [47, 48] with a very basic hydrophilic C-terminal domain, which shows, in the α-helical wheel representation, the characteristic structural features of calmodulinbinding domains [49] . It is tempting to speculate that the calmodulin antagonists reduce the V max of H + -ATPase by acting on these proteolipids in a calmodulin-mediated effect. Calmodulin-mediated regulation could represent an additional regulatory mechanism of this essential enzyme in yeast, the activity of which is under strict genetic and environmental control.
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